Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 187
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we use our immune cells to fight lung disease?

    Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Can Pet Visits Help Kids With Cancer?

    We are in the home stretch! Please consider donating in these final hours so that we'll be able to...

    Backer Badge Funded